Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children
Primary Purpose
Sinusitis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Saline
Gentamycin
Sponsored by
About this trial
This is an interventional treatment trial for Sinusitis
Eligibility Criteria
Inclusion Criteria:
- Healthy children age 4-17
History of "Recurrent" or "Chronic Sinusitis"
- Definition: History must include > 3 months of any or a combination of the following symptoms:
- Nasal congestion/nasal airway obstruction
- Rhinorrhea/Nasal discharge
- Persistent cough (daytime)
- Postnasal drip
- Headache
- Facial pain
- Foul breath
- Intermittent fever
- Caregiver (proxy responsible) able to read and understand English
- Has had at least 3 courses or a total of 21 days of oral antibiotic therapy for above symptoms in the previous 3 months
- Child has a CT scan of the coronal sinus without contrast within two months prior to visit date, which demonstrates and opacification of a single or multiple, ipsilateral or bilateral sinuses.
Exclusion Criteria:
- Inability of caregiver to read and understand English
- Mental retardation, cognitive impairment, or developmental delay
- History of cystic fibrosis
- History of immotile cilia syndrome
- History of immune suppression/immune compromise
- CT scan within past 4 weeks available for review at time of clinic visit which is entirely negative for evidence of sinus disease plus complete absence of any of the above symptoms
- History of endoscopic sinus surgery
- History of patient's inability to tolerate attempted nasal irrigation in the past 6 months
- History of recent use of gentamycin intranasal irrigation or saline irrigation within the past 3 months
- History of presence of nasal polyposis
- History of allergic reaction of any kind to intravenous gentamycin or aminoglycosides in past medical history (for treatment of any infections)
Sites / Locations
- University of Kansas Medical Center
- University of Kansas MedWest
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
2
1
Arm Description
Saline plus Gentamycin
Saline
Outcomes
Primary Outcome Measures
Change in Computed Tomography (CT) Score After Treatment
Change in CT score reflects the Lund-Mackay staging system. Each sinus is scored separately and scores are determined for the right and the left side. The lowest score of 0 represents no opacification in the sinus. A score of 1 represents a partial opacification. A score of 2 represents complete opacification.
Change in Overall Quality of Life
Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.
Secondary Outcome Measures
Change in Overall Quality of Life
Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00465530
Brief Title
Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children
Official Title
Safety and Efficacy of Once Daily Intranasal Gentamycin Irrigation Versus Saline in the Treatment of Pediatric Chronic Sinusitis
Study Type
Interventional
2. Study Status
Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
March 2007 (undefined)
Primary Completion Date
March 2010 (Actual)
Study Completion Date
March 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Julie Wei, MD
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Healthy children may develop symptoms of chronic sinusitis such as chronic cough, chronic runny nose, nasal congestion, even headaches. Such symptoms may persist long after the child gets over other symptoms of a cold and commonly result in the prescription of oral antibiotics. The purpose of this study is to evaluate whether using saline alone or saline plus an antibiotic (gentamycin) to irrigate the nose directly once a day for 6 weeks is effective and safe for the treatment of the above named symptoms. Computerized axial tomography (CAT) scans and quality of life surveys will be used to compare the health of the sinuses before and after treatment, and scored to determine which of the two treatments, saline alone or saline with gentamycin, is more effective in the treatment of this condition. The study hypothesis is that intranasal saline irrigation will work as well as saline plus gentamycin, and that majority of the patients will experience significant improvement after a 6 week treatment period.
Detailed Description
In the pediatric population, rhinosinusitis is a common concern resulting frequently in the frequent and unsuccessful prescription of systemic oral antibiotic therapy. Children typically experience an estimated 6-8 upper respiratory illnesses per year, usually viral, and only 13% are estimated to result in true sinusitis. True and chronic sinusitis, if not adequately treated, may result in long term symptoms including nasal airway obstruction, nasal congestion, persistent mucopurulent rhinorrhea, daytime and nocturnal cough, headaches, daytime fatigue, and even exacerbation or poor control of underlying asthma. A child's quality of life can be severely impacted as is their caretaker's due to days of missed school, frequency of doctor visits and courses of oral antibiotic therapy prescribed for the above mentioned symptoms, which ultimately result in the development of resistant organisms in addition to potential negative side effects associated with systemic oral antibiotic use.
Intranasal saline irrigation is underutilized in the pediatric population, most likely due to the presumption that children will not cooperate nor tolerate the act of irrigation. Saline irrigation of the nose is an inexpensive and generally well tolerated treatment with very little side effects or risks. Rigorous data regarding the efficacy of saline irrigation has become more available in this past decade, with most studies demonstrating a clear improvement in patient quality of life as measured by various study instruments or outcome surveys.
In our protocol, patients will be randomized to receive either saline alone or saline plus gentamycin in the solution form for nasal irrigation once daily for a six week treatment period. Weekly phone calls will be made to check for possible adverse events while patients are on treatment, and at the end of the treatment period another CAT scan will be performed to assess the status of the sinuses. Overall improvement will be determined based on the sinus status on the second CAT scan as well as the quality of life survey filled out by parents.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sinusitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
2
Arm Type
Experimental
Arm Description
Saline plus Gentamycin
Arm Title
1
Arm Type
Placebo Comparator
Arm Description
Saline
Intervention Type
Drug
Intervention Name(s)
Saline
Intervention Description
Intranasal Saline
Intervention Type
Drug
Intervention Name(s)
Gentamycin
Intervention Description
Intranasal irrigation
Primary Outcome Measure Information:
Title
Change in Computed Tomography (CT) Score After Treatment
Description
Change in CT score reflects the Lund-Mackay staging system. Each sinus is scored separately and scores are determined for the right and the left side. The lowest score of 0 represents no opacification in the sinus. A score of 1 represents a partial opacification. A score of 2 represents complete opacification.
Time Frame
Change from Baseline to 6 Weeks
Title
Change in Overall Quality of Life
Description
Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.
Time Frame
3 Weeks to Follow-Up (7 Weeks)
Secondary Outcome Measure Information:
Title
Change in Overall Quality of Life
Description
Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.
Time Frame
Baseline to 3 Weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Healthy children age 4-17
History of "Recurrent" or "Chronic Sinusitis"
Definition: History must include > 3 months of any or a combination of the following symptoms:
Nasal congestion/nasal airway obstruction
Rhinorrhea/Nasal discharge
Persistent cough (daytime)
Postnasal drip
Headache
Facial pain
Foul breath
Intermittent fever
Caregiver (proxy responsible) able to read and understand English
Has had at least 3 courses or a total of 21 days of oral antibiotic therapy for above symptoms in the previous 3 months
Child has a CT scan of the coronal sinus without contrast within two months prior to visit date, which demonstrates and opacification of a single or multiple, ipsilateral or bilateral sinuses.
Exclusion Criteria:
Inability of caregiver to read and understand English
Mental retardation, cognitive impairment, or developmental delay
History of cystic fibrosis
History of immotile cilia syndrome
History of immune suppression/immune compromise
CT scan within past 4 weeks available for review at time of clinic visit which is entirely negative for evidence of sinus disease plus complete absence of any of the above symptoms
History of endoscopic sinus surgery
History of patient's inability to tolerate attempted nasal irrigation in the past 6 months
History of recent use of gentamycin intranasal irrigation or saline irrigation within the past 3 months
History of presence of nasal polyposis
History of allergic reaction of any kind to intravenous gentamycin or aminoglycosides in past medical history (for treatment of any infections)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julie L Wei, M.D.
Organizational Affiliation
University of Kansas Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Facility Name
University of Kansas MedWest
City
Shawnee
State/Province
Kansas
ZIP/Postal Code
66217
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children
We'll reach out to this number within 24 hrs